Why is Remedium Life falling/rising?

As of 18-Sep, Remedium Lifecare Ltd is currently priced at 1.50, showing no change (0.00%). The stock has outperformed its sector by 0.76% today, and its delivery volume has increased by 13.63% compared to the 5-day average, indicating rising investor participation. However, the stock has experienced significant declines over the past year, with a return of -76.44%, and has reported negative results for the last four consecutive quarters, including a substantial fall in net sales of -76.36%. The company's high Debt to EBITDA ratio of -1.00 times and negative ROCE further highlight its financial struggles, contributing to a poor long-term growth outlook.
In the broader market context, the Sensex has increased by 1.80% over the past week, while Remedium Lifecare Ltd has declined by 1.32% during the same period. This underperformance is indicative of the stock's challenges, especially as it has consistently lagged behind the market over the last year, where the broader market (BSE500) generated negative returns of -1.96%. Despite some positive short-term indicators, the overall financial health of the company remains concerning, which is likely influencing investor sentiment and contributing to the stock's recent price stagnation.